"Nebivolol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cardioselective ADRENERGIC BETA-1 RECEPTOR ANTAGONIST (beta-blocker) that functions as a VASODILATOR through the endothelial L-arginine/ NITRIC OXIDE system. It is used to manage HYPERTENSION and chronic HEART FAILURE in elderly patients.
Descriptor ID |
D000068577
|
MeSH Number(s) |
D02.033.100.291.491 D02.092.063.291.503 D03.383.663.283.755 D03.633.100.150.755
|
Concept/Terms |
Nebivolol- Nebivolol
- Alpha,Alpha'-(Iminobis(Methylene))bis(6-Fluoro-3,4-dihydro)-2H-1-benzopyran-2-methanol
R 67555- R 67555
- 67555, R
- R-67555
- R67555
|
Below are MeSH descriptors whose meaning is more general than "Nebivolol".
Below are MeSH descriptors whose meaning is more specific than "Nebivolol".
This graph shows the total number of publications written about "Nebivolol" by people in this website by year, and whether "Nebivolol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2013 | 0 | 1 | 1 |
2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nebivolol" by people in Profiles.
-
Efficacy of nebivolol-valsartan single-pill combination in obese and nonobese patients with hypertension. J Clin Hypertens (Greenwich). 2017 Jun; 19(6):632-639.
-
Comparative Efficacy of Nebivolol and Metoprolol to Prevent Tachycardia-Induced Cardiomyopathy in a Porcine Model. Tex Heart Inst J. 2016 Dec; 43(6):477-481.
-
Nebivolol Acts as a S-Nitrosoglutathione Reductase Inhibitor: A New Mechanism of Action. J Cardiovasc Pharmacol Ther. 2016 09; 21(5):478-85.
-
Nebivolol induces distinct changes in profibrosis microRNA expression compared with atenolol, in salt-sensitive hypertensive rats. Hypertension. 2013 May; 61(5):1008-13.
-
Nebivolol induces endothelium-dependent relaxations of canine coronary arteries. J Cardiovasc Pharmacol. 1991 Jun; 17(6):964-9.